With fears of another recession threatening the West, emerging economies are once again in focus.
However, as China grapples with an economic slowdown, and political and economic uncertainty rule Brazil, investors are betting on Indian markets as the most promising of the emerging economies.
With its young demographic, and the promise of changes to policy to attract private investments, India is poised to record robust growth.
We recommend two Asian American Depository Receipts (ADRs) to include a bite of Asia in your portfolio. They are among a group of growth investments with enough momentum to "beat the bear" in 2016. Both companies offer products and services in high demand and have robust pipelines of business.INFY data by YCharts
IT outsourcing pioneer Infosys is on track to return to its pre-2011 glory.
Infosys was the jewel in India's outsourcing services crown. The company, along with peers Wipro , TCS and Cognizant has contributed a heft part of what is now India's $150 billion IT industry.
But operating margins started going downhill post the retirement of top executives, particularly its widely praised former CEO Narayan Murthy largely due to lack of innovation.
Murthy returned as executive chairman in 2013 to help Infosys regain its lost luster. In 2014, he hired Vishal Sikka formerly of SAP as CEO. The move and others spurred Infosys. Share prices have risen over 20% in the last two years.
Under Sikka's leadership, Infosys has renewed its focus on automation, artificial intelligence and digital technology among others. That's translated to higher revenues and net profits. In the third quarter, Infosys displayed revenue increase of 15.2% year over year and raised full year 2016 revenue guidance to 12.8%-13.2% in constant currency from 10%-12% earlier.
With over 60 customer projects pertaining to the Infosys Automation Platform, over 125 projects on the data processing platform and development of a software platform that can provide solutions for complex business issues, Infosys seems on track to differentiate itself from its peers and achieve its goal of $20 billion in revenue by 2020.
WNS (Holdings) (WNS)
Business process management company WNS Global is so far enjoying a good year. The company recently announced that it had extended service contracts with pharma giant GlaxoSmithKline until December 2020 and Scandinavian Airlines until October 2019.
WNS provides research and analytics services to GSK and has even set up an advanced Knowledge Center under the partnership with the pharma company.
For Scandinavian Airlines, in addition to passenger revenue accounting services, WNS will incrementally provide analytical support, with solutions across risk, audit and compliance.
In the most recent quarter, the company reported revenue of $144.4 million, up 6.2% year over year year and up 2.4% on the quarter. The major verticals that led to the rise in revenues were Shipping and Logistics, Retail/CPG, Travel and Utilities. At least for the last four quarters, WNS has beat analyst estimates on earnings per share.
The company has displayed a strong appetite for organic and inorganic growth as it builds capabilities in health care and analytics. With zero debt, net income growth (three-year average) that dwarfs the industry average, and higher operating and net margins than the industry, WNS boasts a strong balance sheet.
Analysts are bullish on the ADR with nine rating it a Buy, three rating it a Hold and zero rating it a Sell. Analysts have a 12-month price target of $34.50, representing a 19.34% upside from current levels.
85% Accurate Trader gives his Personal Guarantee. He turned $50,000 into $5 million trading this way and for a limited time, he's guaranteeing you at least $67,548 per year in profitable trades if you follow this simple step-by-step process. Click here to see how easy it is to collect thousands of dollars in "Free Money" every month.